These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 17097610)

  • 1. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells.
    Suetsugu A; Nagaki M; Aoki H; Motohashi T; Kunisada T; Moriwaki H
    Biochem Biophys Res Commun; 2006 Dec; 351(4):820-4. PubMed ID: 17097610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of tumorigenic liver cancer stem/progenitor cells.
    Ma S; Chan KW; Hu L; Lee TK; Wo JY; Ng IO; Zheng BJ; Guan XY
    Gastroenterology; 2007 Jun; 132(7):2542-56. PubMed ID: 17570225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.
    Zhu Z; Hao X; Yan M; Yao M; Ge C; Gu J; Li J
    Int J Cancer; 2010 May; 126(9):2067-78. PubMed ID: 19711346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells.
    Lan X; Wu YZ; Wang Y; Wu FR; Zang CB; Tang C; Cao S; Li SL
    Int J Mol Med; 2013 Feb; 31(2):315-24. PubMed ID: 23233126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer.
    Cui F; Wang J; Chen D; Chen YJ
    Oncol Rep; 2011 Mar; 25(3):701-8. PubMed ID: 21174061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
    Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
    Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity.
    Yin S; Li J; Hu C; Chen X; Yao M; Yan M; Jiang G; Ge C; Xie H; Wan D; Yang S; Zheng S; Gu J
    Int J Cancer; 2007 Apr; 120(7):1444-50. PubMed ID: 17205516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
    Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
    Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CD133 promotes the phosphorylation of Erk in U87MG human glioblastoma cells.
    Dong L; Qi N; Ge RM; Cao CL; Lan F; Shen L
    Neurosci Lett; 2010 Nov; 484(3):210-4. PubMed ID: 20800650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133(+) cells isolated from various sources and their role in future clinical perspectives.
    Meregalli M; Farini A; Belicchi M; Torrente Y
    Expert Opin Biol Ther; 2010 Nov; 10(11):1521-8. PubMed ID: 20932225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
    Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY
    Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells.
    Liu YM; Li XF; Liu H; Wu XL
    Oncol Rep; 2015 Dec; 34(6):2977-86. PubMed ID: 26370320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy.
    Li J; Chen JN; Zeng TT; He F; Chen SP; Ma S; Bi J; Zhu XF; Guan XY
    BMC Cancer; 2016 Jan; 16():15. PubMed ID: 26758620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma].
    Wei XD; Zhou L; Cheng L; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):692-6. PubMed ID: 18051573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced tumorigenesis and lymphatic metastasis of CD133+ hepatocarcinoma ascites syngeneic cell lines mediated by JNK signaling pathway in vitro and in vivo.
    Jin Y; Mao J; Wang H; Hou Z; Ma W; Zhang J; Wang B; Huang Y; Zang S; Tang J; Li L
    Biomed Pharmacother; 2013 May; 67(4):337-45. PubMed ID: 23582787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma.
    Kohga K; Tatsumi T; Takehara T; Tsunematsu H; Shimizu S; Yamamoto M; Sasakawa A; Miyagi T; Hayashi N
    J Hepatol; 2010 Jun; 52(6):872-9. PubMed ID: 20395004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of N-linked glycosylation at Asn548 in CD133 decreases its ability to promote hepatoma cell growth.
    Liu Y; Ren S; Xie L; Cui C; Xing Y; Liu C; Cao B; Yang F; Li Y; Chen X; Wei Y; Lu H; Jiang J
    Oncotarget; 2015 Aug; 6(24):20650-60. PubMed ID: 26029999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis.
    Zhong C; Wu JD; Fang MM; Pu LY
    Tumour Biol; 2015 Sep; 36(10):7623-30. PubMed ID: 25921286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of diagnostic utility and expression profiles of stem cell markers (CD133 and CD90) in hepatocellular carcinoma, small cell dysplasia, and cirrhosis.
    Yilmaz G; Akyol G; Cakir A; Ilhan M
    Pathol Res Pract; 2014 Jul; 210(7):419-25. PubMed ID: 24702884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CD133/prominin-1 antisense oligodeoxynucleotide on in vitro growth characteristics of Huh-7 human hepatocarcinoma cells and U251 human glioma cells.
    Yao J; Zhang T; Ren J; Yu M; Wu G
    Oncol Rep; 2009 Oct; 22(4):781-7. PubMed ID: 19724856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.